Sign in
Taking people in United StatesPhase 1

Novel Cellular Therapy for the Treatment of Pain Associated With Chronic Pancreatitis

Key facts

Who runs it
VA Office of Research and Development
Where
Charleston, United StatesSee the site
Trial code
Status
Recruiting
Phase
Phase 1
People taking part
40 people, planned
Started
1 Jan 2024
Expected to end
31 Dec 2027
Type of study
Interventional, 2 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • Mesenchymal stem cells
  • Placebo
Record updated
7 April 2026

Who can take part

Age
18 years to 75 years
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 23 criteriaShow less

Who can take part

  • Age between 18 and 75 years old, male or female
  • Definite chronic pancreatitis M-ANNHEIM criteria (Tsimmerman Ia, 2008) One or more of the following are required:
  • Pancreatic calcifications
  • Moderate or marked ductal lesions
  • Marked and persistent exocrine insufficiency defined as pancreatic steatorrhea markedly reduced by enzyme supplementation
  • Typical histology of an adequate histological specimen
  • Patients who are diagnosed with painful CP for more than 6 months may be constant or may have been waxing and waning/remitting
  • Baseline Izbicki pain score > 30 (Dworkin et al., 2005)
  • Stable dose of opioids for the past 30 days

Who cannot take part

  • Any subject who has had an ongoing alcohol abuse and/or illegal drug dependencies within the past six months
  • Any subject who has received an investigational drug or device within 30 days before randomization or who is expected to receive an investigational drug or device during this study
  • Patients with planned endoscopic or surgical intervention, surgical resection or needle drainage of pancreatic structures in the next 6 months
  • Chronic pain syndromes other than pancreatitis that require daily use of opioids in the past 30 days
  • Congestive Heart Failure NYHA class >1
  • History of Malignancy except for in situ malignancies that have been surgically treated and basal cell skin cancers
  • Evidence of active infection using current antibiotics or with Hepatitis B, C, or HIV
  • Known intravenous contrast allergy causing anaphylaxis
  • Subjects with infected pancreatic pseudocysts or pancreatic walled-off necrotic areas at the time of consent
  • Acute pancreatitis per 2012 revised Atlanta criteria (23) within the last 30 days oThe revised Atlanta classification requires that two or more of the following criteria be met for the diagnosis of acute pancreatitis: (a) abdominal pain suggestive of pancreatitis, (b) serum amylase or lipase level greater than three times the upper normal value, or (c) characteristic imaging findings
  • Hemoglobin of <8.0g/dL, EGFR<60 ml/min, AST or ALT >2 times upper limit of normal, Bilirubin > 1.5 mg/dl unless the subject has confirmed Gilbert syndrome., Platelets <100,000/microliter, HbA1c >10%
  • Females who are pregnant or women of childbearing potential (WOCBP) and males with female partners of childbearing potential who are not willing to use adequate contraception during the study
  • Breastfeeding females
  • Subject unwilling to follow the protocol and assessment

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 75 years old?

This trial is currently available in United States.

  • Ralph H. Johnson VA Medical Center, Charleston, SCCharleston, United StatesContact: Hongjun N Wang, PhDTaking people

About the trial

What the trial wants to find out

The goal of this clinical trial is to test whether adult stem cells, called mesenchymal stem cells (MSCs) collected from the patient's bone marrow can help reduce pain caused by chronic pancreatitis and improve pancreatic function.

The 2 groups in the trial

  • Experimental CohortTreatment being tested

    MSC

    Treatment: Mesenchymal stem cells

  • Validation CohortPlacebo, for comparison

    Placebo

    Treatment: Placebo

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Criteria questions
Built from NCT05925036, who can take part
Record updated
7 April 2026